ArticlePorcine health management2026
Detection, virus isolation, and phylogenetic analysis of PRRSV2 in China from 2022 to 2025.
Article in Porcine health management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPorcine reproductive and respiratory syndrome (PRRS) is one of the most important diseases threatening the global pig industry. It has been reported that PRRSV predominantly circulating in clinical practice in China belongs to the genotype 2 (PRRSV2), comprising four lineages: lineages 1, 3, 5, and 8. Among these, lineage 1 strains are further divided into sublineage 1.5 (NADC34-like strains) and sublineage 1.8 (NADC30-like strains).To further understand the prevalence and variation characteristics of PRRSV2 in China, this study conducted detection, virus isolation, and genetic evolution analysis of PRRSV2 from 2022 to 2025.
resultsThis study employed qRT-PCR to detect PRRSV2 in 23,962 samples collected nationwide from 2022 to 2025, with an average positive detection rate of 33.29%. Phylogenetic analysis based on the ORF5 gene revealed that sublineage 1.8 PRRSV was predominant in China, followed by sublineage 1.5 and lineage 8. A total of 389 PRRSV2 strains were isolated using porcine alveolar macrophage (PAM) cells, of which 59 strains could proliferate in Marc-145 cells. Different amino acid variations, insertions, and deletions were identified in the ORF5 and Nsp2 genes of the 389 PRRSV2 strains. Whole genome sequencing was performed on 79 PRRSV strains, and 93.67% (74 strains) exhibited inter-lineage recombination.
conclusionThis study demonstrates the positive detection rate and predominant strain types of PRRSV2 in China. Sequencing results of isolated PRRSV strains reveals amino acid variations and recombination in the ORF5, Nsp2, and whole genomes. Overall, this study provides data support for the molecular epidemiology of PRRSV2 in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.